PKD1 Compared With PK D2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies

Affiliations

¹ Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
² Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
³ Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio, USA.
⁴ Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
⁵ Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
⁷ Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁸ Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Cortney Steele et al. Kidney Int Rep. 2021.

. 2021 Oct 7;7(1):117-120.

doi: 10.1016/j.ekir.2021.09.013. eCollection 2022 Jan.

¹ Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
² Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
³ Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio, USA.
⁴ Section of Nephrology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
⁵ Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁶ Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
⁷ Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
⁸ Division of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

No abstract available

Cited by

Glioneuronal tumor in an autosomal-dominant polycystic kidney disease patient: a case report and literature review.
Qupp SK, Zeidan MM, Nimer H. Qupp SK, et al. Ann Med Surg (Lond). 2024 Jun 10;86(7):4304-4307. doi: 10.1097/MS9.0000000000002265. eCollection 2024 Jul. Ann Med Surg (Lond). 2024. PMID: 38989164 Free PMC article.
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
St Pierre K, Cashmore BA, Bolignano D, Zoccali C, Ruospo M, Craig JC, Strippoli GF, Mallett AJ, Green SC, Tunnicliffe DJ. St Pierre K, et al. Cochrane Database Syst Rev. 2024 Oct 2;10(10):CD010294. doi: 10.1002/14651858.CD010294.pub3. Cochrane Database Syst Rev. 2024. PMID: 39356039
Prenatal Diagnosis of Autosomal Dominant Polycystic Kidney Disease: Case Report.
Gyokova E, Hristova-Atanasova E, Odumosu E, Andreeva A. Gyokova E, et al. Reports (MDPI). 2025 Apr 23;8(2):56. doi: 10.3390/reports8020056. Reports (MDPI). 2025. PMID: 40710847 Free PMC article.
Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers.
Telis N, McEwen L, Bolze A, Lipschutz JH, Sweer LW, Judge DP, Pawloski PA, Grzymski JJ, Hajek C, Schiabor Barrett KM, Washington NL, Cirulli ET. Telis N, et al. HGG Adv. 2025 Jul 10;6(3):100444. doi: 10.1016/j.xhgg.2025.100444. Epub 2025 Apr 23. HGG Adv. 2025. PMID: 40269498 Free PMC article.

1. Cornec-Le Gall E., Alam A., Perrone R.D. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919–935. doi: 10.1016/S0140-6736(18)32782-X. - DOI - PubMed
1. Ecder T., Schrier R.W. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol. 2009;5:221–228. doi: 10.1038/nrneph.2009.13. - DOI - PMC - PubMed
1. Torres V.E., Cai Y., Chen X., et al. Vascular expression of polycystin-2. J Am Soc Nephrol. 2001;12:1–9. doi: 10.1681/ASN.V1211. - DOI - PubMed
1. MacKay C.E., Leo M.D., Fernández-Peña C., et al. Intravascular flow stimulates PKD2 (polycystin-2) channels in endothelial cells to reduce blood pressure [published correction appears in Elife. 2020;9:e60401] Elife. 2020;9:e56655. doi: 10.7554/eLife.56655. - DOI - PMC - PubMed
1. Pala R., Jamal M., Alshammari Q., Nauli S.M. The roles of primary cilia in cardiovascular diseases. Cells. 2018;7:233. doi: 10.3390/cells7120233. - DOI - PMC - PubMed